Drug delivery by red blood cells

S Biagiotti, MF Paoletti, A Fraternale, L Rossi… - IUBMB …, 2011 - Wiley Online Library
Drug delivery is a growing field of interdisciplinary activities that combine the use of new
materials with the biochemical properties of selected drugs, with the aim of improving their …

The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients

MR Costanzo, A Dipchand, R Starling… - The Journal of heart and …, 2010 - Elsevier
CHAIR: Costanzo MR: Midwest Heart Foundation, Lombard Illinois, USA TASK FORCE 1:
Dipchand A: Hospital for Sick Children, Toronto Ontario, Canada; Starling R: Cleveland …

Sirolimus: the evidence for clinical pharmacokinetic monitoring

SB Stenton, N Partovi, MHH Ensom - Clinical pharmacokinetics, 2005 - Springer
This review seeks to apply a decision-making algorithm to establish whether clinical
pharmacokinetic monitoring (CPM) of sirolimus (rapamycin) in solid organ transplantation is …

Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets

JD Johnson, Z Ao, P Ao, H Li, LJ Dai, Z He… - Cell …, 2009 - journals.sagepub.com
Pancreatic islet transplantation has the potential to be an effective treatment for type 1
diabetes mellitus. While recent improvements have improved 1-year outcomes, follow-up …

Immunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugs

S Biagiotti, L Rossi, M Bianchi, E Giacomini… - Journal of controlled …, 2011 - Elsevier
Cyclosporine A (CsA) and tacrolimus (also known as FK506) are natural compounds with
immunosuppressive activity that have improved the outcome of organ transplantation …

Mechanisms of pharmacokinetic and pharmacodynamic drug interactions associated with ritonavir‐enhanced tipranavir

M Vourvahis, ADM Kashuba - Pharmacotherapy: The Journal …, 2007 - Wiley Online Library
Tipranavir is a nonpeptidic protease inhibitor that has activity against human
immunodeficiency virus strains resistant to multiple protease inhibitors. Tipranavir 500 mg is …

Label-free quantification of Tacrolimus in biological samples by atomic force microscopy

M Menotta, S Biagiotti, L Streppa, L Rossi… - Analytica Chimica …, 2015 - Elsevier
In the present paper we describe an atomic force microscopy (AFM)-based method for the
quantitative analysis of FK506 (Tacrolimus) in whole blood (WB) samples. Current reference …

Treatment with Tacrolimus and Sirolimus Reveals No Additional Adverse Effects on Human Islets In Vitro Compared to Each Drug Alone but They Are Reduced by …

K Kloster-Jensen, A Sahraoui, NT Vethe… - Journal of diabetes …, 2016 - Wiley Online Library
Tacrolimus and sirolimus are important immunosuppressive drugs used in human islet
transplantation; however, they are linked to detrimental effects on islets and reduction of …

Incorporation of Gene‐Environment Interaction Terms Improved the Predictive Accuracy of Tacrolimus Stable Dose Algorithms in Chinese Adult Renal Transplant …

J Tang, J Xu, YL Zhang, R Liu, MZ Liu… - The Journal of …, 2019 - Wiley Online Library
The narrow therapeutic window of tacrolimus necessitates daily monitoring and predictive
algorithms based on genetic and nongenetic factors. In this study, we constructed predictive …

Bioequivalence of two tacrolimus formulations under fasting conditions in healthy male subjects

P Mathew, J Mandal, K Patel, K Soni, G Tangudu… - Clinical …, 2011 - Elsevier
BACKGROUND: Tacrolimus is a macrolide immunosuppressant indicated for prophylaxis of
transplant rejection. The European regulatory authorities require comparative bioavailability …